Early Access — free while we kick the tires
EdgarHawk

MANHARD KIMBERLY

Director

Director
1 filing analyzed · 1 company · Latest 2024-08-30

Companies

Company Buys Sells Direction
Inhibrx Biosciences, Inc. INBX 1 0 Net buying

Activity

August 2024
high
Buy
10,000 shares
$139,800
Significance 6/10

Director Kimberly Manhard buys 10.0K shares of INBX at $13.98; stock down 63.2% from 52-week high. Cluster buy with 3 other insiders in 14 days.

Director Kimberly Manhard purchased 10,000 shares at $13.98, establishing an initial position after holding none previously. The purchase occurs against a backdrop of sharp stock weakness—the stock trades at $14.56, representing a 63.2% decline from the 52-week high of $39.56. Notably, this transaction is part of a cluster pattern: 3 other insiders have also purchased shares within the same 14-day window, which may indicate coordinated or consensus-driven buying by the board/management tier. The 90-day price trend of -10.4% suggests ongoing downward pressure, though the recent 30-day change of +0.3% signals stabilization. Investors should monitor whether this cluster buying reflects informed conviction in fundamental recovery or simply opportunistic accumulation at depressed levels, and track whether the stock sustains the recent price stabilization.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access